Emergent BioSolutions to Participate in Investor Conferences
January 04 2021 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s executive management team will participate in the
following investor conferences in the first quarter of 2021:
- 39th Annual J.P. Morgan Healthcare
Conference January 11 to 14, 2021Company presentation
scheduled on January 11 at 8:20am EST
- J.P. Morgan 2021 Global High Yield & Leveraged
Finance ConferenceMarch 1 to 3, 2021Presentation date and
time will be updated on the Emergent website as the information
becomes available.
- Cowen 41st Annual Health Care
ConferenceMarch 1 to 4, 2021Presentation date and time
will be updated on the Emergent website as the information becomes
available.
For conferences where a presentation is planned,
the company’s webcast presentation may include a discussion of the
company's recent business developments as well as its financial
results and guidance. The webcasts will be available both live, if
possible, and by replay, and will be accessible from the Emergent
website.
About Emergent
BioSolutionsEmergent BioSolutions is a global life
sciences company whose mission is to protect and enhance life.
Through our specialty products and contract development and
manufacturing services, we are dedicated to providing solutions
that address public health threats. Through social responsibility,
we aim to build healthier and safer communities. We aspire to
deliver peace of mind to our patients and customers so they can
focus on what’s most important in their lives. In working together,
we envision protecting or enhancing 1 billion lives by 2030. For
more information, visit our website and follow us on LinkedIn,
Twitter, and Instagram.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Miko B. NeriSenior
Director, Global Communications & Public
Affairs240-631-3392nerim@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024